國立虎尾科技大學 |

Predictive Biomarkers in Oncology = Applications in Precision Medicine /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Predictive Biomarkers in Oncology/ edited by Sunil Badve, George Louis Kumar.
其他題名:	Applications in Precision Medicine /
其他作者:	Badve, Sunil.
面頁冊數:	XXI, 642 p. 156 illus., 153 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Pathology. -
電子資源:	https://doi.org/10.1007/978-3-319-95228-4
ISBN:	9783319952284

Predictive Biomarkers in Oncology = Applications in Precision Medicine /
Predictive Biomarkers in OncologyApplications in Precision Medicine /[electronic resource] :edited by Sunil Badve, George Louis Kumar. - 1st ed. 2019. - XXI, 642 p. 156 illus., 153 illus. in color.online resource.

Introduction to Predictive Biomarkers: definitions and characteristics -- Introduction to clinical trials, clinical trial designs and statistical terminology used for predictive biomarker research and validation -- Overview of Methods Used in Predictive Biomarker Studies in a Molecular Anatomic Pathology Laboratory -- Significance of Immunohistochemistry and In Situ Hybridization Techniques for Predictive Biomarker Studies -- Overview of PCR-based Technologies and Multiplexed Gene Analysis for Biomarker Studies -- Introduction to Microarray Technology -- Digital and Computational Pathology for Biomarker Discovery -- Detection of Predictive Biomarkers Using Liquid Biopsies -- Measurement of Predictive Cancer Biomarkers by Flow Cytometry -- Personalized Cancer Treatment and Patient Stratification Using Massive Parallel Sequencing (MPS) and Other OMICs Data -- Bioinformatic Methods and Resources for Biomarker Discovery, Validation, Development, and Integration -- Overview of Cell Signaling Pathways in Cancer -- Steroid Hormone and Nuclear Receptor signaling pathways -- Protein kinase C Signaling in Carcinogenesis -- Roles of Rho/ROCK in Cancer Signaling -- Mitogen Activated Protein Kinase (MAPK) Signaling -- Notch Signaling Pathway in Carcinogenesis -- Signaling of the ErbB receptor Family in Carcinogenesis and the Development of Targeted Therapies -- Signaling Pathways in Tumor Angiogenesis and Anti-angiogenic Therapies in Human Cancer -- Role of PI3K/AKT/mTOR in Cancer Signaling -- Met Signaling in Carcinogenesis -- Role of Insulin-like Growth Factor Receptors in Cancer Signaling -- Role of Wnt/β-catenin Pathway in Cancer Signaling -- Hedgehog Signaling in Carcinogenesis -- TGF-β and the SMAD Signaling Pathway in Carcinogenesis -- Role of JAK-STAT Pathway in Cancer Signaling -- NF-kB signaling pathways in Carcinogenesis -- Immune-Signaling in Carcinogenesis -- Predictive Biomarkers and Targeted Therapies in Immuno-Oncology -- Role of Protein Tyrosine Phosphatases in Cancer Signaling -- Predictive and Prognostic Biomarkers in Myeloid Neoplasms -- Predictive Biomarkers and Targeted Therapies for Lymphoid Malignancies -- Targeted Therapies for Pediatric Central Nervous System Tumors -- Predictive Biomarkers and Targeted Therapies in Adult Brain Cancers -- Predictive Biomarkers and Targeted Therapies in Breast Cancer -- Predictive Biomarkers in Lung Cancer -- Predictive Biomarkers and Targeted Therapies in Genitourinary Cancers -- Predictive Biomarkers and Targeted Therapies in Colorectal Cancer -- Predictive Markers and Targeted Therapies in Gastroesophageal Cancer (GEC) -- Predictive Biomarkers and Targeted Therapies in Hepatic, Pancreatic, and Biliary Cancers -- Gynecological Cancers & Head and Neck Cancers -- Predictive Biomarkers and Targeted Therapies in Head and Neck Cancer -- Predictive Biomarkers and Targeted Therapies in the Skin -- Predictive Biomarkers and Targeted Therapies in Sarcomas -- Predictive Markers and Targeted Therapies in Thyroid Cancer and Selected Endocrine Tumors -- The Response Evaluation Criteria in Solid Tumors (RECIST) -- IVDs and FDA Marketing Authorizations: A General Overview of FDA Approval Process of an IVD Companion Diagnostic Device in Oncology -- Quality Control of Immunohistochemical and In Situ hybridization Predictive Biomarkers for Patient Treatment: Experience from International Guidelines and International Quality Control Schemes -- Use of Companion Diagnostics (CDx) and Predictive Biomarkers for Cancer Targeted Therapy. Clinical Applications in Precision Medicine -- Policy issues in the clinical development and use of predictive biomarkers for molecular targeted therapies -- Role of central laboratories in research, validation and application of predictive biomarkers -- Prominent Precision Medicine Clinical Trials in Oncology Around the World -- Precision Medicine Clinical Trials: Successes and Disappointments, Challenges and Opportunities. Lessons Learnt -- FDA Approved Targeted Therapies in Oncology.

This book provides a collection of ingeniously organized, well-illustrated, and up-to-date authoritative chapters divided into five sections that are clear and easy to understand. Early sections provide a concise and richly illustrated overview of biomarkers by introducing basic terminologies and analyzing how predictive biomarkers are altered, expressed, or amplified across cancer types. Later sections explore how these biomarkers play a role in patient stratification and treatment, ultimately leading up to detailed descriptions of precision medicine clinical trials across the world. Predictive Biomarkers in Oncology: Applications in Precision Medicine serves as a definitive guide for practicing pathologists, pathology residents, and personal in the pharmaceutical or diagnostic industry interested in learning on how “predictive biomarkers” are used in precision cancer therapy.

ISBN: 9783319952284

Standard No.: 10.1007/978-3-319-95228-4doiSubjects--Topical Terms:

668553
Pathology.

LC Class. No.: RB1-214

Dewey Class. No.: 616.07

Predictive Biomarkers in Oncology = Applications in Precision Medicine /
LDR:06233nam a22003855i 4500 001 1009161
003 DE-He213
005 20200704165559.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783319952284 $9 978-3-319-95228-4
024 7 $a 10.1007/978-3-319-95228-4 $2 doi
035 $a 978-3-319-95228-4
050 4 $a RB1-214
072 7 $a MMF $2 bicssc
072 7 $a MED067000 $2 bisacsh
072 7 $a MKF $2 thema
082 0 4 $a 616.07 $2 23
245 1 0 $a Predictive Biomarkers in Oncology $h [electronic resource] : $b Applications in Precision Medicine / $c edited by Sunil Badve, George Louis Kumar.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a XXI, 642 p. 156 illus., 153 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Introduction to Predictive Biomarkers: definitions and characteristics -- Introduction to clinical trials, clinical trial designs and statistical terminology used for predictive biomarker research and validation -- Overview of Methods Used in Predictive Biomarker Studies in a Molecular Anatomic Pathology Laboratory -- Significance of Immunohistochemistry and In Situ Hybridization Techniques for Predictive Biomarker Studies -- Overview of PCR-based Technologies and Multiplexed Gene Analysis for Biomarker Studies -- Introduction to Microarray Technology -- Digital and Computational Pathology for Biomarker Discovery -- Detection of Predictive Biomarkers Using Liquid Biopsies -- Measurement of Predictive Cancer Biomarkers by Flow Cytometry -- Personalized Cancer Treatment and Patient Stratification Using Massive Parallel Sequencing (MPS) and Other OMICs Data -- Bioinformatic Methods and Resources for Biomarker Discovery, Validation, Development, and Integration -- Overview of Cell Signaling Pathways in Cancer -- Steroid Hormone and Nuclear Receptor signaling pathways -- Protein kinase C Signaling in Carcinogenesis -- Roles of Rho/ROCK in Cancer Signaling -- Mitogen Activated Protein Kinase (MAPK) Signaling -- Notch Signaling Pathway in Carcinogenesis -- Signaling of the ErbB receptor Family in Carcinogenesis and the Development of Targeted Therapies -- Signaling Pathways in Tumor Angiogenesis and Anti-angiogenic Therapies in Human Cancer -- Role of PI3K/AKT/mTOR in Cancer Signaling -- Met Signaling in Carcinogenesis -- Role of Insulin-like Growth Factor Receptors in Cancer Signaling -- Role of Wnt/β-catenin Pathway in Cancer Signaling -- Hedgehog Signaling in Carcinogenesis -- TGF-β and the SMAD Signaling Pathway in Carcinogenesis -- Role of JAK-STAT Pathway in Cancer Signaling -- NF-kB signaling pathways in Carcinogenesis -- Immune-Signaling in Carcinogenesis -- Predictive Biomarkers and Targeted Therapies in Immuno-Oncology -- Role of Protein Tyrosine Phosphatases in Cancer Signaling -- Predictive and Prognostic Biomarkers in Myeloid Neoplasms -- Predictive Biomarkers and Targeted Therapies for Lymphoid Malignancies -- Targeted Therapies for Pediatric Central Nervous System Tumors -- Predictive Biomarkers and Targeted Therapies in Adult Brain Cancers -- Predictive Biomarkers and Targeted Therapies in Breast Cancer -- Predictive Biomarkers in Lung Cancer -- Predictive Biomarkers and Targeted Therapies in Genitourinary Cancers -- Predictive Biomarkers and Targeted Therapies in Colorectal Cancer -- Predictive Markers and Targeted Therapies in Gastroesophageal Cancer (GEC) -- Predictive Biomarkers and Targeted Therapies in Hepatic, Pancreatic, and Biliary Cancers -- Gynecological Cancers & Head and Neck Cancers -- Predictive Biomarkers and Targeted Therapies in Head and Neck Cancer -- Predictive Biomarkers and Targeted Therapies in the Skin -- Predictive Biomarkers and Targeted Therapies in Sarcomas -- Predictive Markers and Targeted Therapies in Thyroid Cancer and Selected Endocrine Tumors -- The Response Evaluation Criteria in Solid Tumors (RECIST) -- IVDs and FDA Marketing Authorizations: A General Overview of FDA Approval Process of an IVD Companion Diagnostic Device in Oncology -- Quality Control of Immunohistochemical and In Situ hybridization Predictive Biomarkers for Patient Treatment: Experience from International Guidelines and International Quality Control Schemes -- Use of Companion Diagnostics (CDx) and Predictive Biomarkers for Cancer Targeted Therapy. Clinical Applications in Precision Medicine -- Policy issues in the clinical development and use of predictive biomarkers for molecular targeted therapies -- Role of central laboratories in research, validation and application of predictive biomarkers -- Prominent Precision Medicine Clinical Trials in Oncology Around the World -- Precision Medicine Clinical Trials: Successes and Disappointments, Challenges and Opportunities. Lessons Learnt -- FDA Approved Targeted Therapies in Oncology.
520 $a This book provides a collection of ingeniously organized, well-illustrated, and up-to-date authoritative chapters divided into five sections that are clear and easy to understand. Early sections provide a concise and richly illustrated overview of biomarkers by introducing basic terminologies and analyzing how predictive biomarkers are altered, expressed, or amplified across cancer types. Later sections explore how these biomarkers play a role in patient stratification and treatment, ultimately leading up to detailed descriptions of precision medicine clinical trials across the world. Predictive Biomarkers in Oncology: Applications in Precision Medicine serves as a definitive guide for practicing pathologists, pathology residents, and personal in the pharmaceutical or diagnostic industry interested in learning on how “predictive biomarkers” are used in precision cancer therapy.
650 0 $a Pathology. $3 668553
650 0 $a Oncology . $3 1253469
650 2 4 $a Oncology. $3 593951
700 1 $a Badve, Sunil. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1115250
700 1 $a Kumar, George Louis. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1303062
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319952277
776 0 8 $i Printed edition: $z 9783319952291
856 4 0 $u https://doi.org/10.1007/978-3-319-95228-4
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)